Neovasc Inc G5Z3-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 05/07/21 CEST
0.678quote price arrow down-0.063 (-8.50%)
52 week range
0.56 - 3.00

...

Loading . . .
  • Open0.66
  • Day High0.678
  • Day Low0.66
  • Prev Close0.741
  • 52 Week High3.00
  • 52 Week High Date06/10/20
  • 52 Week Low0.56
  • 52 Week Low Date12/08/20

Key Stats

  • Market Cap24.98M
  • Shares Out28.93M
  • 10 Day Average Volume2,659.09
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-11.95

KEY STATS

  • Open0.66
  • Day High0.678
  • Day Low0.66
  • Prev Close0.741
  • 52 Week High3.00
  • 52 Week High Date06/10/20
  • 52 Week Low0.56
  • 52 Week Low Date12/08/20
  • Market Cap24.98M
  • Shares Out28.93M
  • 10 Day Average Volume2,659.09
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-11.95

RATIOS/PROFITABILITY

  • EPS (TTM)-1.55
  • P/E (TTM)-0.44
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Neovasc Inc

There is no recent news for this security.

Profile

MORE
Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical...
Steven Rubin Esq., J.D.
Chairman
Fred Colen
President
Bill Little
Chief Operating Officer
Christopher Clark
Chief Financial Officer
Aaron Chalekian
Vice President
Address
Richmond, 5138-13562 Maycrest Way
Richmond, BC
V6V 2J7
Canada